209 employees
Vical develops biopharmaceutical drugs to prevent and treat chronic or life-threatening infectious diseases.
1987
Vical Incorporated raised undisclosed on January 1, 1992
Investors: Venrock
Vical Incorporated raised undisclosed on September 29, 1988
Investors: Hilman Ventures and Morgenthaler